Alleviation of COVID-19 Symptoms and Reduction in Healthcare Utilization Among High-Risk Patients Treated With Nirmatrelvir/Ritonavir (NMV/R): A phase 3 randomized trial

By sjmartinez • November 14, 2024

Hammond J, Leister-Tebbe H, Gardner A, Abreu P, Bao W, Wisemandle W, Ansari W, Harrington MA, Simón-Campos A, Chew KW, Pypstra R, Rusnak JM. Alleviation of COVID-19 Symptoms and Reduction in Healthcare Utilization Among High-Risk Patients Treated With Nirmatrelvir/Ritonavir (NMV/R): A phase 3 randomized trial. Clin Infect Dis. 2024 Nov 11:ciae551. doi: 10.1093/cid/ciae551. Epub ahead of print. PMID: 39523543.

Tags: COVID-19 drug therapy, EPIC-HR, Infectious Diseases, nirmatrelvir, Publications, ritonavir, Symptoms

High usage of telephone telemedicine among people living with HIV at two federally qualified health centers in Los Angeles

Hoffman R, Walker D, Butler D, Tseng CH, Shoptaw S, Currier JS, Gladstein J, Moucheraud C. High usage of telephone telemedicine among people living with[...]

Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges. Reply

Rana AI, Castillo-Mancilla J, Landovitz RJ. Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges. Reply. N Engl J Med. 2026 May 14;394(19):1963-1964. doi:[...]

Comparing Phenotypic Susceptibility Profiles of Neisseria gonorrhoeae for Tetracycline and Doxycycline

Liu L, Branda JA, Azzato F, Klausner JD, Kersh EN, Pasricha S, Allan-Blitz LT. Comparing Phenotypic Susceptibility Profiles of Neisseria gonorrhoeae for Tetracycline and Doxycycline.[...]